Re: Roberti R, Iannone LF, Palleria C, et al. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1786681

Robyn Laube¹, Christian P Selinger^{2

3}

Affiliations

¹ Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
² Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
³ University of Leeds, Leeds, UK.

Comment

Robyn Laube et al. Curr Med Res Opin. 2020 Oct.

. 2020 Oct;36(10):1627-1628.

doi: 10.1080/03007995.2020.1799775. Epub 2020 Aug 5.

Robyn Laube¹, Christian P Selinger^{2

3}

¹ Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
² Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
³ University of Leeds, Leeds, UK.

No abstract available

Comment on

Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy.
Roberti R, Iannone LF, Palleria C, De Sarro C, Spagnuolo R, Barbieri MA, Vero A, Manti A, Pisana V, Fries W, Trifirò G, Naturale MD, Larussa T, De Francesco AE, Bosco V, Donato di Paola E, Citraro R, Luzza F, Bennardo L, Rodinò S, Doldo P, Spina E, Russo E, De Sarro G. Roberti R, et al. Curr Med Res Opin. 2020 Sep;36(9):1457-1463. doi: 10.1080/03007995.2020.1786681. Epub 2020 Jul 27. Curr Med Res Opin. 2020. PMID: 32573307